Who owns Nurix Therapeutics, Inc.?
Institutional ownership of NRIX from SEC Form 13F filings across 141 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
141
13F holders
$1.27B
value, 2026 filers
56.6%
of shares outstanding (58.7M sh)
31
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of NRIX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.8M | $212.8M | 0.0% | 8.5% | -1.7% |
| 2 | FMR LLC | 5.5M | $133.1M | 0.0% | 5.3% | -1.0% |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.4M | $131,892 | 0.0% | 5.2% | +65.2% |
| 4 | MORGAN STANLEY | 4.8M | $115.5M | 0.0% | 4.6% | -3.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $109.1M | 0.0% | 4.3% | -49.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $61.6M | 0.0% | 2.4% | +0.7% |
| 7 | Pictet Asset Management Holding SA | 2.4M | $57.0M | 0.1% | 2.3% | -13.8% |
| 8 | ARK Investment Management LLC | 1.8M | $43.5M | 0.3% | 1.7% | +4.2% |
| 9 | Capital World Investors | 1.8M | $43.4M | 0.0% | 1.7% | +100.1% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $36.0M | 0.0% | 1.4% | +34.5% |
| 11 | CITADEL ADVISORS LLC | 1.5M | $35.8M | 0.0% | 1.4% | +9.9% |
| 12 | Woodline Partners LP | 1.1M | $25.8M | 0.1% | 1% | -42.5% |
| 13 | Sumitomo Mitsui Trust Group, Inc. | 983,462 | $23.9M | 0.0% | 0.9% | -16.7% |
| 14 | Amova Asset Management Americas, Inc. | 983,462 | $23.8M | 0.3% | 0.9% | -16.7% |
| 15 | UBS Group AG | 917,117 | $22.2M | 0.0% | 0.9% | -6.1% |
| 16 | NORTHERN TRUST CORP | 876,070 | $21.3M | 0.0% | 0.8% | +2.5% |
| 17 | BANK OF AMERICA CORP /DE/ | 842,089 | $20.4M | 0.0% | 0.8% | +5.0% |
| 18 | Sixth Street Partners Management Company, L.P.NEW | 833,296 | $20.2M | 3.5% | 0.8% | new |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 833,296 | $20.2M | 0.0% | 0.8% | -9.8% |
| 20 | Nuveen, LLC | 825,833 | $20.0M | 0.0% | 0.8% | +1.6% |
| 21 | GOLDMAN SACHS GROUP INC | 813,589 | $19.7M | 0.0% | 0.8% | -38.3% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 686,338 | $16.7M | 0.0% | 0.7% | +8.6% |
| 23 | Handelsbanken Fonder AB | 633,000 | $15,357 | 0.0% | 0.6% | +15.7% |
| 24 | RAYMOND JAMES FINANCIAL INC | 593,262 | $14.4M | 0.0% | 0.6% | +67.7% |
| 25 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIPNEW | 477,141 | $11.6M | 0.0% | 0.5% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.